The STAAR Low-Grade Serous Ovarian Cancer Foundation is hosting a conference to unite LGSOC patients for the first time, aiming to foster community and address the unique challenges and recent research advancements related to this rare cancer.

This two-day event is scheduled for February 7-8, 2025, in Houston, Texas, and will feature a tour of the research laboratories at The University of Texas MD Anderson Cancer Center.

As the organization has expanded and developed, it has remained committed to its fundamental values and mission. It continues to back LGSOC research in Australia, Canada, the United Kingdom, the United States, and New Zealand.

On the inaugural World Low-Grade Serous Ovarian Cancer Day, the organization revealed that its global LGSOC efforts will be rebranded as the Low-Grade Serous Ovarian Cancer Initiative, alongside the launch of its redesigned website. This new designation signifies their steadfast commitment to the LGSOC community across the globe.